一项阶梯楔形整群随机对照试验方案:循证医院住院护理框架(HIRAID® Inpatient)的实施评价
本研究将循证HIRAID®护理框架适配于医院住院环境,通过实时德尔菲法和共同设计完成适配,并制定实施策略。随后在澳大利亚两个州三个卫生服务机构的35个住院病房、1259名护士中开展II型混合有效性-实施阶梯楔形整群随机对照试验,每月收治患者4050例,以RE-AIM框架评价实施与保真度,关注可预防的护士相关临床恶化、医院获得性并发症、患者和照护者体验及护理记录与沟通质量。
要点
- 研究采用实时德尔菲法和共同设计将HIRAID®框架适配于住院环境。
- 将开展阶梯楔形整群随机对照试验,纳入35个病房的1259名护士。
- 主要关注可预防的护士相关临床恶化、医院获得性并发症等结局。
核心结论
- HIRAID® Inpatient旨在通过标准化的循证评估、决策和行动框架,预防不良事件、改善患者体验并加强临床沟通,从而优化护士对医院护理质量与安全的贡献。
研究设计与样本
- 研究分为三个阶段:第一阶段使用实时德尔菲技术和共同设计将HIRAID®适配于医院住院环境;第二阶段采用解释性混合方法研究,结合员工调查和焦点小组,以行为改变理论为指导制定实施策略;第三阶段采用II型混合有效性-实施设计,包括阶梯楔形整群随机对照试验。
- 试验纳入澳大利亚两个州三个卫生服务机构10家医院35个住院病房的1259名护士,四个整群根据地理和临床治理确定,每月收治患者4050例。
- 样本量计算基于既往研究,假设组内相关系数3%、显著性水平5%(双侧)、把握度80%,采用Woertman的阶梯楔形估计方法。
- 实施与保真度评价使用RE-AIM框架,通过常规收集数据、指导文件以及干预前后对患者、照护者、护理和医疗人员的调查来检验七项研究假设。
主要发现
- 原文未报告研究结果。
关键数值与推荐
- 关注结局包括可预防的护士相关临床恶化发生率、医院获得性并发症、患者和照护者照护体验以及护理记录和沟通质量。
- 样本量计算假设组内相关系数3%、显著性水平5%(双侧)、把握度80%。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Preventable adverse events in Australian hospitals are a significant safety issue, causing harm, death and increased healthcare costs. Many stem from inadequate recognition of, or response to, clinical deterioration by nurses that suggest gaps in current nursing practice frameworks. Responding to health sector demand, this study will adapt the evidence-informed HIRAID® nursing framework for use in hospital inpatient settings, implement and evaluate the standardised HIRAID® Inpatient framework to improve the quality and safety of inpatient hospital care. METHODS: HIRAID® will be adapted for the hospital inpatient setting using a real-time Delphi technique and co-design with frontline hospital inpatient nurses, consumers, managers, physicians and allied health clinicians (Phase 1). An explanatory mixed methods study incorporating staff surveys and focus groups, informed by behaviour change theory, will be used to generate the implementation strategy (Phase 2). The intervention will be trialled with 1259 nurses from 35 inpatient wards (10 hospitals) across three health services in two Australian states, using a Type II hybrid effectiveness-implementation design, including a Stepped-Wedge clustered Randomised Control Trial (Phase 3). There will be four clusters, determined by geography and clinical governance, where 4050 patients are admitted per month. These clusters were selected due to their direct admission of acutely unwell patients that are at a high risk of experiencing adverse events. Routinely collected data, guidance documents, and pre- and post-intervention surveys of patients, carers, nursing and medical staff will be used to test the seven study hypotheses. Sample size calculations were based on prior research, assuming a 3% intra-class correlation, 5% significance (two-tailed) and 80% power, and using Woertman's Stepped-Wedge estimate approach. Evaluation of implementation and fidelity will be assessed using the RE-AIM framework. Outcomes of interest include rates of preventable nurse-associated clinical deterioration, hospital-acquired complications, patient and carer experiences with care, and quality of nursing documentation and communication. DISCUSSION: HIRAID® Inpatient aims to optimise nurses' contribution to the quality and safety of hospital nursing care by preventing adverse events, improving patient experiences and strengthening clinical communication through a standardised, evidence-informed framework for assessment, decision-making and action. TRIAL REGISTRATION: Australian and New Zealand Clinical Trial Registry, ACTRN12625000639426. Registered on 17 June 2025, https://anzctr.org.au/ACTRN12625000639426.aspx . PROTOCOL VERSION: Version 5.0 30 April 2025.
引用
- Curtis K, Considine J, Lam MK, et al. Implementation evaluation of an evidence-informed hospital inpatient nursing framework (HIRAID® Inpatient): a protocol for a stepped-wedge cluster RCT. Trials. 2025. PMID: 41339957. doi:10.1186/s13063-025-09313-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。